NCT02514070View on ClinicalTrials.gov

Comparison of EPA and DHA-Rich Fish Oils on Lipoprotein Metabolism In Adults

PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

October 30, 2015

Primary Completion Date

July 23, 2019

Study Completion Date

July 23, 2019

Conditions
Lipoprotein MetabolismPCSK9Proteomics
Interventions
DRUG

EPA-rich fish oil

4 gel capsules, 3 times/day for 6 weeks

DRUG

DHA-rich fish oil

4 gel capsules, 3 times/day for 6 weeks

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT02514070 - Comparison of EPA and DHA-Rich Fish Oils on Lipoprotein Metabolism In Adults | Biotech Hunter | Biotech Hunter